Chronic Obstructive Pulmonary Disease Treatment Pipeline Lacks Robust Innovation; According to New Research
Despite an influx of new therapies over recent years, the Chronic Obstructive Pulmonary Disease (COPD) treatment market has a number of unmet needs, and the innovation in its product development pipeline is lagging in comparison to other indications, According to Research.
View full press release